Showing results (41-50 of 237) with videos related to

Sort By:
Pageof 24
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|June 27, 2022
Usefulness of simultaneous impulse oscillometry and spirometry with airway response to bronchodilator in the diagnosis of asthmatic coughNamiko Taniuchi, Mitsunori Hino, Akiko Yoshikawa, et al.
Annals of the American Thoracic Society|March 22, 2026
Low-Dose vs. Standard-Dose Nintedanib at Initiation in Fibrosing ILD: A Target-Trial Emulation of Treatment Persistence and Lung FunctionShota Kaburaki, Toru Tanaka, Koichiro Kamio, et al.
CEN Case Reports|August 18, 2021
Clinicopathological characteristics of kidney injury in non-small cell lung cancer patients under combination therapy including pembrolizumabSae Aratani, Teppei Sugano, Akira Shimizu, et al.
Hepato-Gastroenterology|May 30, 2008
Gastric emptying in patients with palliative stenting for malignant gastric outlet obstructionIruru Maetani, Takeo Ukita, Tomoko Tada, et al.
Gastrointestinal Endoscopy|April 7, 2005
Efficacy of an overtube for reducing the risk of peristomal infection after PEG placement: a prospective, randomized comparison studyIruru Maetani, Masatoshi Yasuda, Masahiro Seike, et al.
Respiratory Medicine Case Reports|June 11, 2025
Enfortumab vedotin induced interstitial lung disease: A first case report with pathological evidence from transbronchial lung cryobiopsyShota Kaburaki, Toru Tanaka, Koichiro Kamio, et al.
Proteomics|September 8, 2004
Proteomic signature of human cancer cellsMasahiro Seike, Tadashi Kondo, Kazuyasu Fujii, et al.
Internal Medicine (Tokyo, Japan)|October 15, 2025
A Case of Drug-induced Interstitial Lung Disease with a Hypersensitivity Pneumonitis Pattern Following Pembrolizumab plus Epirubicin and Cyclophosphamide Therapy: First Report with Pathological FindingsShota Kaburaki, Toru Tanaka, Koichiro Kamio, et al.
Oncotargets and Therapy|September 5, 2024
Safety and Efficacy of Gefitinib Administration After Osimertinib-Induced Interstitial Lung Disease: A Six-Case SeriesKaoruko Shimbu, Kakeru Hisakane, Naohiro Kadoma, et al.
Respiratory Medicine|August 20, 2023
Minimal effective dose of maintenance steroid therapy for relapse of cryptogenic organizing pneumoniaKenichiro Atsumi, Kakeru Hisakane, Erika Mikami, et al.
Pageof 24